Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
18,491,349
-
Shares change
-
+9,313,789
-
Total reported value, excl. options
-
$80,617,885
-
Value change
-
+$40,696,600
-
Number of buys
-
40
-
Number of sells
-
-20
-
Price
-
$4.36
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q1 2020
63 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q1 2020.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,491,349 shares
.
Largest 10 shareholders include Bellevue Group AG (3,518,889 shares), FMR LLC (2,444,400 shares), FRANKLIN RESOURCES INC (2,026,900 shares), BlackRock Inc. (1,797,894 shares), BVF INC/IL (1,564,373 shares), VICTORY CAPITAL MANAGEMENT INC (1,370,027 shares), VANGUARD GROUP INC (1,271,070 shares), CITADEL ADVISORS LLC (924,034 shares), CHI Advisors LLC (458,887 shares), and STATE STREET CORP (427,900 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.